About Us

About Us

Meaningful, innovative and evidence-based analysis to
help inform key decision making.

Our goal is to be the business intelligence partner of choice for companies in the healthcare arena looking for meaningful, innovative and evidence-based analysis to inform their key decision making. As a trusted and reliable partner, GBI Research helps clients to better understand their business environment, compete successfully within it, and to achieve growth.

At GBI Research, we leverage extensive proprietary databases and employ novel data interrogation methodologies to generate new and meaningful analyses and insights.

Our content and coverage are informed by close collaboration with a global network of domain-specific external partners; this allows us to deliver novel, thought-provoking and idea-generating insights that clients would normally struggle to access.

Our in-house team of researchers and analysts – typically with MBAs, PhDs and MScs, as well as considerable healthcare industry experience is located across the UK, US and Asia Pacific. The team provides expert and insightful commentary to support evidence-based analyses of established and emerging markets.

More than 2,000 clients benefit from the GBI Research product set. Reports are available to purchase as individual research reports or via our online subscription platform, request a demo today to see how it works.

Analyst Views

30 Apr 15
Diversified Pipeline has the Potential to Stimulate Growth ....
Rheumatoid Arthritis (RA) is a chronic, progressive and currently incurable autoimmune di.....
Read post
30 Apr 15
Novel Entrants, Anticipated Launches and Growing Treatment ....
Nearly 125 million people worldwide, or 2–3% of the global population, currently suffer f.....
Read post

White Papers

07 May 15
A Review of Asthma Therapeutics....
The following White Paper examines the global burden of asthma as well as current trends ....
Read post
18 Jun 14
Investigating the Clinical Trial Landscape....
The need for intelligence related to the clinical trial landscape has never been greater ....
Read post

Press Releases

12 May 15
Muscular Dystrophy Treatment Pipeline Offers Hope for Impro....
The highly diverse and innovative pipeline for Duchenne Muscular Dystrophy (DMD) and Beck.....
Read post
07 May 15
Asia-Pacific Market for Psoriasis Treatment Almost Doubling....
The Asia-Pacific (APAC) treatment market for psoriasis will almost double in value, from .....
Read post